Vendor Management for Pharmaceuticals, Biologicals, and Medical Devices

This webinar provides an overview of FDA’s requirements for vendor management and oversight for pharmaceuticals, biologicals, and medical devices.

$999.00
Introducing
Purchase using Webinar All-Access Pass
One user get unlimited access to all upcoming and recorded webinars for one year (350+)

Recorded Version Only

(PPT + Recorded Streaming Link)

$299.00
1x Person - Unlimited viewing for 6 Months (For multiple locations contact Customer Care)
rec Recorded Link and Ref. material will be available in My Account Section
Last Recorded Date: May-2021

CD or USB Drive Only

(PPT + Recorded Training File)

$399.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days
Customer Care

Fax: +1-650-362-2367

Email: customercare@fdatrainingalert.com

Follow us:
Why Should You Attend:

FDA requires pharmaceutical, biological, and medical devices manufacturers to establish and maintain control over their suppliers to ensure the purchased goods or services meet Good Manufacturing Practices.

In this webinar, you will learn FDA’s expectations for the implementation and on-going operation of an effective vendor oversight program.

Areas Covered in the Webinar:
  • Pharmaceuticals
  • Biologicals
  • Medical devices
  • Finished Product (contract manufacturing)
  • Chemicals (including Active Pharmaceutical Ingredients and excipients)
  • Packaging Materials (primary, secondary, & tertiary)
  • Labelling (printed) Materials
  • Services (including contract laboratories and contract sterilizers)
Who Will Benefit:

Pharmaceutical, biological, and medical device company personnel working in production, R&D, regulatory affairs, QA, and QC.

Instructor Profile:
Paul Larocque Paul Larocque

President, Acerna Inc

Paul Larocque is the President of Acerna Inc., a pharmaceutical, biological, and medical device consultancy, which provides good manufacturing practice and regulatory affairs services to a global clientele. For the past years consulting, and previously in industry, Paul’s focus was FDA compliance matters.

Previously, Paul held executive positions with Pfizer, Allergan, and Teva Pharmaceuticals, all related to sterile products. He was also head of the unit responsible for the review of the chemistry and manufacturing parts of drug submissions at Health Canada. He also chaired the industry committee that negotiated the sterile products chapter of the GMP regulations at Health Canada. He has provided expert sworn testimony in various legal cases.

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

You Recently Viewed